Longitudinal assessment of disparities in pancreatic cancer care: A retrospective analysis of the National Cancer Database

Mahip Grewal,Victor J. Kroon,Sarah R. Kaslow,Anthony M. Sorrentino,Megan D. Winner,John D. Allendorf,Paresh C. Shah,Diane M. Simeone,Theodore H. Welling,Russell S. Berman,Steven M. Cohen,Christopher L. Wolfgang,Greg D. Sacks,Ammar A. Javed
DOI: https://doi.org/10.1002/wjs.12431
IF: 3.282
2024-12-11
World Journal of Surgery
Abstract:Background The existence of sociodemographic disparities in pancreatic cancer has been well‐studied but how these disparities have changed over time is unclear. The purpose of this study was to longitudinally assess patient management in the context of sociodemographic factors to identify persisting disparities in pancreatic cancer care. Methods Using the National Cancer Database, patients diagnosed with pancreatic ductal adenocarcinoma from 2010 to 2017 were identified. The primary outcomes were surgical resection and/or receipt of chemotherapy. Outcome measures included changes in associations between sociodemographic factors (i.e., sex, age, race, comorbidity index, SES, and insurance type) and treatment‐related factors (i.e., clinical stage at diagnosis, surgical resection, and receipt of chemotherapy). For each year, associations were assessed via univariate and multivariate analyses. Results Of 75,801 studied patients, the majority were female (51%), White (83%), and had government insurance (65%). Older age (range of OR 2010–2017 [range‐OR]:0.19–0.29), Black race (range‐OR: 0.61–0.78), lower SES (range‐OR: 0.52–0.94), and uninsured status (range‐OR: 0.46–0.71) were associated with lower odds of surgical resection (all p
surgery
What problem does this paper attempt to address?